Treatment Information

Back

Liver Cancer treatment details. Biologic therapy.

National Taiwan University Hospital, Taipei, Taiwan Region.

Survival: monthsCountry:Taiwan Region
Toxiciy Grade:4City/State/Province:Taipei
Treatments:Biologic therapyHospital:National Taiwan University Hospital
Drugs:Journal:Link
Date:May 2012

Description:

Patients:
This phase 2 study involved 19 advanced hepatocellular carcinoma patients, 18 of whom were male. The median patient age was 54 years.

Treatment:
Patients were treated with the biologic therapy agent vandetanib, which is a VEGF inhibitor that interferes with tumor blood supply.

Toxicities:
The most severe toxicities were of grade 4 and included diarrhea, liver failure, and hand-foot skin reaction.

Results:
The median overall survival was 5.95 months.

Support:
This study was supported by AstraZeneca.

Correspondence: Dr. Ann-Lii Cheng; email: [email protected]



Back